ArticleTherapeutic advances in gastroenterology2026
Acceptability and tolerability of risankizumab maintenance therapy administered via on-body injector in patients with Crohn's disease: Results of the ACCEPT-OBI study.
Anthony Buisson et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.